These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3913455)
1. Abnormal binding of an anti-amnion antibody to epidermal basement membrane provides a novel diagnostic probe for junctional epidermolysis bullosa. Kennedy AR; Heagerty AH; Ortonne JP; Hsi BL; Yeh CJ; Eady RA Br J Dermatol; 1985 Dec; 113(6):651-9. PubMed ID: 3913455 [TBL] [Abstract][Full Text] [Related]
2. 19-DEJ-1, a hemidesmosome-anchoring filament complex-associated monoclonal antibody. Definition of a new skin basement membrane antigenic defect in junctional and dystrophic epidermolysis bullosa. Fine JD; Horiguchi Y; Couchman JR Arch Dermatol; 1989 Apr; 125(4):520-3. PubMed ID: 2649012 [TBL] [Abstract][Full Text] [Related]
3. Identification of an epidermal basement membrane defect in recessive forms of dystrophic epidermolysis bullosa by LH 7:2 monoclonal antibody: use in diagnosis. Heagerty AH; Kennedy AR; Leigh IM; Purkis P; Eady RA Br J Dermatol; 1986 Aug; 115(2):125-31. PubMed ID: 3527251 [TBL] [Abstract][Full Text] [Related]
4. KF-1 monoclonal antibody defines a specific basement membrane antigen defect in dystrophic forms of epidermolysis bullosa. Fine JD; Breathnach SM; Hintner H; Katz SI J Invest Dermatol; 1984 Jan; 82(1):35-8. PubMed ID: 6361168 [TBL] [Abstract][Full Text] [Related]
5. Epidermolysis bullosa: variability of expression of cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens in clinically uninvolved skin. Fine JD J Invest Dermatol; 1985 Jul; 85(1):47-9. PubMed ID: 3891876 [TBL] [Abstract][Full Text] [Related]
6. Evidence for a functional defect of the lamina lucida in recessive dystrophic epidermolysis bullosa demonstrated by suction blisters. Tidman MJ; Eady RA Br J Dermatol; 1984 Oct; 111(4):379-87. PubMed ID: 6487542 [TBL] [Abstract][Full Text] [Related]
7. Applicability of 19-DEJ-1 monoclonal antibody for the prenatal diagnosis or exclusion of junctional epidermolysis bullosa. Fine JD; Holbrook KA; Elias S; Anton-Lamprecht I; Rauskolb R Prenat Diagn; 1990 Apr; 10(4):219-29. PubMed ID: 2195497 [TBL] [Abstract][Full Text] [Related]
8. LDA-1 monoclonal antibody. An excellent reagent for immunofluorescence mapping studies in patients with epidermolysis bullosa. Fine JD; Gay S Arch Dermatol; 1986 Jan; 122(1):48-51. PubMed ID: 3510588 [TBL] [Abstract][Full Text] [Related]
9. 19-DEJ-1, a monoclonal antibody to the hemidesmosome-anchoring filament complex, is the only reliable immunohistochemical probe for all major forms of junctional epidermolysis bullosa. Fine JD Arch Dermatol; 1990 Sep; 126(9):1187-90. PubMed ID: 2396835 [TBL] [Abstract][Full Text] [Related]
10. Immunohistological localization of three basement membrane components in various forms of epidermolysis bullosa. Kero M; Peltonen L; Foidart JM; Savolainen ER J Cutan Pathol; 1982 Oct; 9(5):316-28. PubMed ID: 7142519 [TBL] [Abstract][Full Text] [Related]
11. Immunofluorescence mapping of antigenic determinants within the dermal-epidermal junction in the mechanobullous diseases. Hintner H; Stingl G; Schuler G; Fritsch P; Stanley J; Katz S; Wolff K J Invest Dermatol; 1981 Feb; 76(2):113-8. PubMed ID: 6161971 [TBL] [Abstract][Full Text] [Related]
12. Antigenic expression of integrin alpha 6 beta 4 in junctional epidermolysis bullosa. Phillips RJ; Aplin JD; Lake BD Histopathology; 1994 Jun; 24(6):571-6. PubMed ID: 8063286 [TBL] [Abstract][Full Text] [Related]
13. Using immunofluorescence (antigen) mapping in the diagnosis and classification of epidermolysis bullosa: a first report from Iran. Barzegar M; Asadi-Kani Z; Mozafari N; Vahidnezhad H; Kariminejad A; Toossi P Int J Dermatol; 2015 Oct; 54(10):e416-23. PubMed ID: 26220012 [TBL] [Abstract][Full Text] [Related]
14. Hemidesmosomes show abnormal association with the keratin filament network in junctional forms of epidermolysis bullosa. McMillan JR; McGrath JA; Tidman MJ; Eady RA J Invest Dermatol; 1998 Feb; 110(2):132-7. PubMed ID: 9457907 [TBL] [Abstract][Full Text] [Related]
15. Epidermolysis bullosa acquisita. Incidence in patients with basement membrane zone antibodies. Zhu XJ; Niimi Y; Bystryn JC Arch Dermatol; 1990 Feb; 126(2):171-4. PubMed ID: 2134155 [TBL] [Abstract][Full Text] [Related]
16. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. Woodley DT; Briggaman RA; O'Keefe EJ; Inman AO; Queen LL; Gammon WR N Engl J Med; 1984 Apr; 310(16):1007-13. PubMed ID: 6369131 [TBL] [Abstract][Full Text] [Related]
17. Ultrastructure and molecular pathogenesis of epidermolysis bullosa. Shinkuma S; McMillan JR; Shimizu H Clin Dermatol; 2011; 29(4):412-9. PubMed ID: 21679868 [TBL] [Abstract][Full Text] [Related]